(Senior) Director, Medical Value Liaison

Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that we are developing for cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease.

Mineralys is a fully remote company.

For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn.

 

(Senior) Director, Medical Value Liaison

The (Senior) Director Medical Value Liaison serves as a field-based scientific expert, engaging healthcare professionals and key stakeholders on clinical and research information for Mineralys’ products. Responsibilities include building professional relationships with HCPs, Medical Thought Leaders, Payors, Managed Care Organizations, and government employees. Collaborating with the Market Access team, the MVL/Sr. MVL connects with payors and decision-makers while ensuring compliance with all regulations. As part of the medical affairs team, the MVL/Sr. MVL provides therapeutic area expertise and insights, acting as a scientific partner to internal and external stakeholders.

Responsibilities:

• Contribute to the development and standardization of key Medical Affairs policies, processes, and internal guidance documents.
• Provides timely clinical, economic, and scientific product updates proactively or in response to unsolicited requests per standard operating procedure (including Dossier) to formulary decision makers or similar entities
• Knowledgeable regarding role of value evidence as used by payor decision makers to inform adoption and diffusion decisions
• Covers select Congresses with the expectations of attending sessions, managing the medical information booth, hosting debriefs, and providing executive summary to the appropriate members of the leadership and cross-functional team
• Ensure policies, procedures, and guidance are adhered to and Perform all Company business in accordance with all regulations (e.g. EEO FDA, OSHA, PDMA, EPA PhRMA, etc.)
• Functions as the primary subject matter expert for Mineralys Medical Affairs and Market Access Teams to provide product and pipeline therapeutic area expertise
• Contribute scientific and medical support for the Market Access team, in alignment with corporate objectives.
• Identify, establish, and develop relationships with key national and regional thought leaders and working closely with the Market Access team to engage payors and Key Decision Makers and while developing a strong understanding of territory specific healthcare systems and payor practices.
• Works closely with the Market Access team to serve as a scientific resource at payor accounts and integrated delivery networks when requested
• Develop a tactical customer-centric medical engagement plan in alignment with management

Skills:

• Significant leadership experience in the pharmaceutical industry with the ability to work independently and collaboratively in cross functional team environment
• Encourages collaboration, innovation and new ideas while integrating information from various sources, seeks leadership sponsorship as needed.
• Demonstrated ability to develop and foster relationships with internal and external stakeholders.
• Drives for results- creates and nurtures a performance-based culture of continuous improvement, addressing concerns and conflict proactively.
• Demonstrated ability to create departmental capabilities, processes, and procedures to ensure alignment with desired outcomes.

 Qualifications:

• Advanced degree in the scientific discipline required (MD, PhD, PharmD, NP/PA, MSN with direct payor experience, MSL experience with Health Economics and Outcomes Research (HEOR) experience, or a related field)
• Knowledge of regional-specific and national healthcare systems, HEOR, and payors
• Deep understanding of US healthcare industry trends, and in-depth knowledge of the US healthcare delivery system, including payors and organized providers and ability to apply this understanding in support of field-based activities
• Ability to translate data-driven evidence into decisions, discu